Cushing v. Tomoka Medical Lab, Inc.

CourtDistrict Court, M.D. Florida
DecidedDecember 23, 2024
Docket8:19-cv-02997
StatusUnknown

This text of Cushing v. Tomoka Medical Lab, Inc. (Cushing v. Tomoka Medical Lab, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cushing v. Tomoka Medical Lab, Inc., (M.D. Fla. 2024).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

UNITED STATES OF AMERICA ex rel. JACQUELINE CUSHING,

Plaintiff, v. Case No. 8:19-cv-2997-VMC-TGW RAJEN SHAH, et al.,

Defendants. _______________________________/ ORDER This matter is before the Court on consideration of Defendant Rajen Shah’s Motion to Vacate Final Default Judgment (Doc. # 99), filed on October 2, 2024. The United States of America responded in opposition on October 23, 2024. (Doc. # 102). For the reasons that follow, the Motion is denied. I. Background On December 6, 2019, Relator Jacqueline Cushing filed a qui tam complaint against Mr. Shah and several businesses, asserting three Federal False Claims Act counts: one Florida False Claims Act count, one Tennessee Medicaid False Claims Act count, and one Tennessee False Claims Act count. (Doc. # 1). In part, Relator alleged that Mr. Shah was “defrauding Medicare, Medicaid and other healthcare programs through the Defendant laboratories he owns and operates.” (Id. at 2). According to Mr. Shah, he “engaged attorney Mark Thomas of Thomas Health Law Group, PA to represent [him] in connection with the legal issues raised in this case and related matters.” (Doc. # 99 Ex. 8 at ¶ 4). Mr. Thomas did not enter a notice of appearance on the docket in the span of

this case. However, Mr. Shah indicates that Mr. Thomas advised and billed him on matters relating to this action. (Doc. # 99 Exs. 1-7). Mr. Shah’s Motion includes an invoice from Thomas Health Law, PA billing for services relating to this case during August 2022. (Doc. # 99 Ex. 1). On August 9, 2022, the United States filed its complaint in intervention. (Doc. # 24). In it, the United States asserted the following counts against Mr. Shah: one count of presenting false claims, one count of making and using false records and statements to get false claims paid, and one count of avoiding an obligation to refund under the False Claims

Act (“FCA”), 31 U.S.C. § 3729, as well as one count of unjust enrichment. (Id. at 39-44). The United States further alleged that “rather than perform the standard urinalysis ordered by the providers, [Mr.] Shah direct[ed] the laboratories to perform (and bill for) the much more profitable Urine PCR test.” (Id. at 2-3). The United States served the defendants with the complaint and filed a waiver of service as to all defendants, including Mr. Shah. (Doc. # 51). Mr. Thomas signed the waiver, and the answer was due on November 21, 2022. (Id.). However, an answer was not filed. After serving discovery on the defendants and not receiving any responses, the United States filed a motion to

compel discovery. (Doc. # 56). Mr. Shah again did not respond, although the certificate of service states that the motion was served upon Mr. Thomas by email. (Id. at 7). The United States filed a motion for entry of clerk’s default on November 23, 2022, and the certificate of service indicates that this motion was also served upon Mr. Thomas by email. (Doc. # 57). The Clerk entered default against Mr. Shah on November 28, 2022. (Doc. # 59). On December 21, 2022, the United States subsequently filed its motion for default judgment (Doc. # 67), to which Mr. Shah did not respond. On January 20, 2023, Mr. Thomas emailed Mr. Shah “keeping

[him] updated as to [the United States’] pleadings in the Cushing case” and “highly recommend[ing] that none of the named defendants maintain ownership of any assets that can be seized.” (Doc. # 99 Ex. 5). Mr. Shah’s Motion indicates that he and Mr. Thomas again communicated by email regarding this case in June 2023. (Doc. # 99 Ex. 6). In part, Mr. Thomas wrote that he had “expected a default judgment,” and that Mr. Shaw had “assured [him] that none of the named defendants in the attached lawsuit had any assets, so the judgment would be essentially meaningless.” (Id.). On August 23, 2023, Magistrate Judge Thomas G. Wilson entered a Report and Recommendation that the motion for

default judgment be granted and damages be awarded to the government against Mr. Shah in the amount of $105,634,097.50. (Doc. # 74 at 26). The Report and Recommendation thoroughly discussed Mr. Shah’s failure to appear or respond, the United States satisfying the elements of the three FCA counts against Mr. Shah, and the damages Mr. Shah would owe. (Id. at 4, 7- 20, 26). On August 24 and 25, 2023, the United States served copies of the Report and Recommendation upon Mr. Shah’s wife at their home and Mr. Thomas respectively. (Doc. # 77). According to Mr. Shah, Mr. Thomas billed him for reviewing the Report and Recommendation on August 25, 2023. (Doc. # 99

at 12; Doc. # 99 Ex. 7). Although the Report and Recommendation advised that any objections must be filed within fourteen days (Doc. # 74 at 27), Mr. Shah did not object. On September 21, 2023, the Court adopted the Report and Recommendation and granted the United States’ motion for default judgment. (Doc. # 78). On October 5, 2023, the United States filed its motion for entry of final default judgment against Mr. Shah in the amount of $105,634,097.50. (Doc. # 79). The motion stated that “the United States conferred with counsel for the defendants who advised that the ‘defendants will not take a

position as to the [m]otion.’” (Id. at 2). The certificate of service again stated that the motion had been served upon Mr. Thomas by email. (Id. at 3). And Mr. Shah again did not respond nor otherwise appear. Thus, final default judgment was entered against the defendants, including Mr. Shah, on October 10, 2023. (Doc. # 80). Now, just under a year later on October 2, 2024, Mr. Shah moves to vacate the default judgment entered against him. (Doc. # 99). Specifically, he claims that: his prior counsel in this case (1) never appeared in this action despite the fact that it was pending for nearly four years prior to the Default Judgment; (2) provided legal advice regarding asset protection, which was outside of counsel’s expertise, demonstrably grossly incorrect, and could have exposed Mr. Shah to criminal liability, and (3) recklessly advised Mr. Shah that allowing the Default Judgment to be entered uncontested would cause Mr. Shah no further legal or financial trouble concerning the issues and allegations that arose within this case. (Id. at 1-2). The United States has responded (Doc. # 102), and the Motion is ripe for review. II. Legal Standard Mr. Shah seeks to vacate the Court’s default judgment pursuant to Federal Rules of Civil Procedure 60(b) and 55(c). (Doc. # 99 at 7-8, 12-15, 24). “The Court may set aside an entry of default for good

cause, and it may set aside final default judgment under Rule 60(b).” Fed. R. Civ. P. 55(c). That is, a default judgment may be set aside under the provisions of Rule 60(b), while an entry of default may be set aside under the provisions of Rule 55(c). Rule 60(b)(1) allows a court to set aside a default judgment based on “mistake, inadvertence, surprise, or excusable neglect.” “To establish mistake, inadvertence, or excusable neglect under Rule 60(b)(1), a defaulting party must show that: ‘(1) it had a meritorious defense that might have affected the outcome; (2) granting the motion would not

result in prejudice to the non-defaulting party; and (3) a good reason existed for failing to reply to the complaint.’” Valdez v. Feltman (In re Worldwide Web Systems, Inc.), 328 F.3d 1291, 1295 (11th Cir. 2003).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Cushing v. Tomoka Medical Lab, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/cushing-v-tomoka-medical-lab-inc-flmd-2024.